Get the Stockscreener App
197.85
0.17%
0.34
After Hours:
197.00
-0.85
-0.43%
Krystal Biotech Inc stock is traded at $197.85, with a volume of 617.86K.
It is up +0.17% in the last 24 hours and up +7.90% over the past month.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
See More
Previous Close:
$197.51
Open:
$197.75
24h Volume:
617.86K
Relative Volume:
1.78
Market Cap:
$5.73B
Revenue:
$290.51M
Net Income/Loss:
$89.16M
P/E Ratio:
66.17
EPS:
2.99
Net Cash Flow:
$119.18M
1W Performance:
+4.17%
1M Performance:
+7.90%
6M Performance:
+19.07%
1Y Performance:
+12.17%
1-Day Range:
$184.02
$198.98
1-Week Range:
$183.26
$198.98
52-Week Range:
$122.80
$207.84
Krystal Biotech Inc Stock (KRYS) Company Profile
Name
Krystal Biotech Inc
Sector
Industry
Phone
(412) 586-5830
Address
2100 WHARTON STREET, PITTSBURGH, PA
Compare KRYS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
197.85 | 5.72B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-25 | Initiated | Jefferies | Buy |
| Aug-06-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-20-23 | Initiated | Goldman | Buy |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-12-23 | Initiated | Citigroup | Buy |
| Sep-07-23 | Initiated | Berenberg | Buy |
| Apr-18-23 | Initiated | Stifel | Buy |
| Feb-28-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-25-22 | Downgrade | Goldman | Buy → Neutral |
| Jan-18-22 | Initiated | BofA Securities | Buy |
| Jul-20-21 | Upgrade | Goldman | Neutral → Buy |
| Sep-18-20 | Initiated | B. Riley FBR | Buy |
| Jun-04-20 | Initiated | Evercore ISI | Outperform |
| Sep-24-19 | Initiated | Goldman | Neutral |
| Aug-06-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-24-19 | Reiterated | Chardan Capital Markets | Buy |
| Jun-24-19 | Reiterated | H.C. Wainwright | Buy |
| May-30-19 | Initiated | Guggenheim | Buy |
| Sep-11-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Krystal Biotech Inc Stock (KRYS) Latest News
Krystal's Q3: Platform Designation Adds Pipeline Leverage As Vyjuvek Scales (Rating Upgrade) - Seeking Alpha
Krystal Biotech Inc (KRYS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Global ... - Yahoo Finance
Krystal Biotech targets global expansion for VYJUVEK with launches in Germany, France, and Japan amid pipeline acceleration - MSN
Krystal Biotech Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Transcript : Krystal Biotech, Inc., Q3 2025 Earnings Call, Nov 03, 2025 - MarketScreener
Krystal Biotech (KRYS) Q3 2025 Earnings Transcript - AOL.com
Is Krystal Biotech Inc. stock gaining market shareJuly 2025 Trade Ideas & Stock Timing and Entry Methods - newser.com
What macro factors could drive Krystal Biotech Inc. (4KB) stock higher2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Earnings call transcript: Krystal Biotech Q3 2025 beats EPS forecasts, shares dip - Investing.com
Will Krystal Biotech Inc. see short term momentumMarket Weekly Review & Low Drawdown Trading Techniques - newser.com
Krystal Biotech’s Profits Rose As Vyjuvek Reached New Markets - Finimize
Tick level data insight on Krystal Biotech Inc. volatilityDip Buying & Free Weekly Watchlist of Top Performers - newser.com
Krystal Biotech (KRYS) Projects Significant Expenses for FY25 - GuruFocus
Krystal Biotech Inc Surpasses Q3 Estimates with $2.74 EPS and $97.8 Million Revenue - GuruFocus
Why retail investors favor Krystal Biotech Inc. stockTrade Entry Summary & Verified Short-Term Trading Plans - newser.com
Earnings Flash (KRYS) Krystal Biotech Posts Q3 EPS $2.66, vs. FactSet Est of $0.95 - MarketScreener
Earnings Flash (KRYS) Krystal Biotech, Inc. Reports Q3 Revenue $97.8M, vs. FactSet Est of $93.2M - MarketScreener
Krystal Biotech Announces Third Quarter 2025 Financial and Operating Results - The Manila Times
Krystal Biotech, Inc. SEC 10-Q Report - TradingView
Krystal Biotech Q3 net income triples - TradingView
Will Krystal Biotech Inc. (4KB) stock issue positive guidanceJuly 2025 WrapUp & Long-Term Safe Return Strategies - newser.com
Will breakout in Krystal Biotech Inc. lead to full recovery2025 Earnings Impact & Daily Volume Surge Trade Alerts - newser.com
How Krystal Biotech Inc. (4KB) stock trades under stagflation2025 Winners & Losers & Fast Entry High Yield Tips - newser.com
Torray Investment Partners LLC Makes New $1.59 Million Investment in Krystal Biotech, Inc. $KRYS - MarketBeat
Analyzing Krystal Biotech Inc. with multi timeframe chartsJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
How to integrate Krystal Biotech Inc. into portfolio analysis toolsTrade Risk Assessment & Daily Entry Point Trade Alerts - newser.com
Can Krystal Biotech Inc. (4KB) stock expand revenue streamsJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
Why Krystal Biotech Inc. stock is recommended by analystsShare Buyback & Stock Portfolio Risk Management - newser.com
Institutional scanner results for Krystal Biotech Inc.2025 Valuation Update & Weekly High Return Opportunities - newser.com
Is Krystal Biotech Inc. stock a safe buy before earningsTrade Analysis Report & Verified Swing Trading Watchlist - newser.com
Should you hold or exit Krystal Biotech Inc. nowMarket Activity Summary & Fast Moving Market Watchlists - newser.com
Published on: 2025-11-02 02:39:07 - newser.com
Is Krystal Biotech Inc. stock safe for conservative investorsJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com
Is it time to cut losses on Krystal Biotech Inc.Market Sentiment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Is Krystal Biotech Inc. stock ready for a breakoutQuarterly Trade Summary & High Win Rate Trade Tips - newser.com
Krystal Biotech Inc Stock (KRYS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):